At the time of writing, Gamida Cell Ltd [GMDA] stock is trading at $0.38, up 6.51%. Until recently, the best way to gauge how the stock has performed was to look at its short-term value. The GMDA shares have gain 13.28% over the last week, with a monthly amount drifted -0.55%, and not seem to be holding up well over a long-time horizon.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
On 23, February 2024, Gamida Cell Data Presented at the 2024 Tandem Meetings of ASTCT® and CIBMTR®. In a post published today on Yahoo Finance, Expanded access program (EAP) data for omidubicel are consistent with Phase 3 trial results on rates of hematopoietic recovery and infections following stem cell transplant with Omisirge® (omidubicel-onlv).
From an analyst’s perspective:
Gamida Cell Ltd [NASDAQ: GMDA] stock has seen the most recent analyst activity on November 01, 2021, when Alliance Global Partners initiated its Buy rating and assigned the stock a price target of $11. On May 26, 2020, Piper Sandler initiated with a Overweight rating and assigned a price target of $13 on the stock. H.C. Wainwright started tracking the stock assigning a Buy rating and suggested a price target of $15 on April 27, 2020. Needham initiated its recommendation with a Buy and recommended $23 as its price target on November 26, 2018. Oppenheimer started tracking with a Outperform rating for this stock on November 21, 2018, and assigned it a price target of $15. In a note dated November 20, 2018, RBC Capital Mkts initiated an Outperform rating and provided a target price of $20 on this stock.
For the past year, the stock price of Gamida Cell Ltd fluctuated between $0.22 and $2.51. Currently, Wall Street analysts expect the stock to reach $7 within the next 12 months. Gamida Cell Ltd [NASDAQ: GMDA] shares were valued at $0.38 at the most recent close of the market. An investor can expect a potential return of 1742.11% based on the average GMDA price forecast.
Analyzing the GMDA fundamentals
Gross Profit Margin for this corporation currently stands at -0.32% with Operating Profit Margin at 108.47%, Pretax Profit Margin comes in at -114.34%, and Net Profit Margin reading is -146.95%. To continue investigating profitability, this company’s Return on Assets is posted at -0.84, Equity is 8.12 and Total Capital is 0.75. Upon thorough examination of the company’s fundamental financial framework, it becomes apparent that the debt-to-equity ratio stands at 223.08.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 0.3640 points at the first support level, and at 0.3451 for the second support level. However, for the 1st resistance point, the stock is sitting at 0.3959, and for the 2nd resistance point, it is at 0.4089.
Gamida Cell Ltd [GMDA] reported earnings per share of -$0.01 for its fiscal quarter that ended on 9/29/2023. Based on the Wall Street analysts’ estimates, the company was expected to report earnings of -$0.17/share, meaning a difference of $0.16 and a surprise factor of 94.10%. By comparison, the stated earnings for the previous quarter ended on 6/29/2023 were -$0.31 per share as compared to estimates of -$0.19 per share, a difference of -$0.12 representing a surprise of -63.20%.
Ratios To Look Out For
It is important to note that Gamida Cell Ltd [NASDAQ:GMDA] has a current ratio of 3.32. As well, the Quick Ratio is 3.20, while the Cash Ratio is 2.93. Considering the valuation of this stock, the price to sales ratio is 75.82, the price to book ratio is 112.65.
